作者
Seoungkyun Kim, Manse Kim, Secheon Jung, Kiyoon Kwon, Junyong Park, Sukhwan Kim, Inchan Kwon, Giyoong Tae
发表日期
2019/9/10
期刊
Journal of Controlled Release
卷号
309
页码范围
181-189
出版商
Elsevier
简介
Therapeutic proteins are indispensable in the treatment of various human diseases. Despite the many benefits of therapeutic proteins, they also exhibit diverse side effects. Therefore, reducing unwanted side effects of therapeutic proteins as well as enhancing their therapeutic efficacy are very important in developing therapeutic proteins. Urate oxidase (UOX) is a therapeutic enzyme that catalyzes the conversion of uric acid (UA) into a soluble metabolite, and it is used clinically for the treatment of hyperuricemia. Since UA degradation by UOX generates H2O2 (a cytotoxic side product), UOX was co-delivered with catalase-mimic nanoparticles (AuNPs) using biocompatible pluronic-based nanocarriers (NCs) to effectively reduce H2O2-associated toxicity in cultured cells and to enhance UA degradation efficiency in vivo. Simple temperature-dependent size changes of NCs allowed co-encapsulation of both UOX and …
学术搜索中的文章
S Kim, M Kim, S Jung, K Kwon, J Park, S Kim, I Kwon… - Journal of Controlled Release, 2019